Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CellNovation
El Paso, Texas, USA
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
CellNovation Technology Corporation is a healthcare company specializing in advanced wound care solutions. Based in El Paso, Texas, the company focuses on the development and commercialization of topical treatments for acute and chronic wounds, including diabetic foot ulcers and pressure sores. Its flagship product, Recelltis, is a topical wound cream designed to promote healing in Stage 1 to Stage 4 wounds. CellNovation also offers skin protection products, such as mineral sunscreens, and antibiotic refill kits for wound management.
- Therapeutic areas
- EndocrinologyDermatology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on CellNovation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CellNovation.